CAMP Q4 2020 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$88M-8.9% YoY

Gross Profit

$35M39.8% margin

Operating Income

-$20M-22.7% margin

Net Income

-$24M-26.9% margin

EPS (Diluted)

$-0.68

QoQ Revenue Growth

+5.4%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$7M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$442M

Total Liabilities

$343M

Stockholders' Equity

$99M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$88M	$97M	-8.9%
Gross Profit	$35M	$37M	-5.1%
Operating Income	-$20M	-$4M	-400.7%
Net Income	-$24M	-$7M	-219.4%

Revenue Segments

Product

$58M66%

Application Subscriptions And Other Services

$30M34%

Geographic Segments

UNITED STATES

$61M69%

E M E A

$14M16%

South America

$7M8%

Asia Pacific

$4M5%

All Other

$2M2%